Detalles de la búsqueda
1.
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
N Engl J Med
; 363(25): 2406-15, 2010 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21082868
2.
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
Am J Cardiol
; 119(3): 388-396, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27956003
3.
A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
Am J Cardiol
; 120(4): 569-576, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28624096
4.
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
J Clin Lipidol
; 9(1): 65-71, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25670362
Resultados
1 -
4
de 4
1
Próxima >
>>